药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rosoxacin
ORM-12741
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with ORM-12741.
Rosoxacin
Deoxyepinephrine
Bromocriptine may decrease the hypertensive activities of Deoxyepinephrine.
Rosoxacin
Theodrenaline
Bromocriptine may decrease the hypertensive activities of Theodrenaline.
Rosoxacin
Gilteritinib
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Gilteritinib.
Rosoxacin
Eticlopride
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Eticlopride.
Rosoxacin
Fallypride
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Fallypride.
Rosoxacin
Clebopride
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Clebopride.
Rosoxacin
JNJ-37822681
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with JNJ-37822681.
Rosoxacin
AS-8112
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with AS-8112.
Rosoxacin
Bromopride
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Bromopride.
Rosoxacin
YKP-1358
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with YKP-1358.
Rosoxacin
Alizapride
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Alizapride.
Rosoxacin
Carphenazine
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Carphenazine.
Rosoxacin
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Bromocriptine.
Rosoxacin
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Bromocriptine.
Rosoxacin
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Bromocriptine.
Rosoxacin
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Bromocriptine.
Rosoxacin
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Bromocriptine.
Rosoxacin
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Bromocriptine.
Rosoxacin
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Bromocriptine.